Nanoparticle trends and hotspots in lung cancer diagnosis from 2006-2023: a bibliometric analysis DOI Creative Commons
Yilun Wang,

Zhang Yaojing,

Hongcan Shi

et al.

Frontiers in Oncology, Journal Year: 2024, Volume and Issue: 14

Published: Dec. 20, 2024

Background Lung cancer possesses the highest incidence and mortality rates among malignancies globally. Despite substantial advancements in oncology, it is frequently diagnosed at an advanced stage, resulting a poor prognosis. Over recent decades, swift progress of nanotechnology has precipitated extensive utilization nanomaterials as carriers diagnosis therapy. The deployment nanoparticles innovative diagnostic strategy aspires to enable earlier detection lung cancer, thereby permitting intervention enhancing This study endeavors deepen our understanding this domain through comprehensive analysis employing bibliometric tools. Method Related articles were retrieved from Web Science Core Collection January 1st, 2006, December 14st, 2023. Thereaf CiteSpace, VOSviewer online platform bibliometrics ( http://bibliometric.com/ ) utilized visually analyze Author/Country/Institutions/Cited Journals/Keyword, et al. Results A total 966 for study. unveils progressive increase annual publications within field, with China forefront publication volume, followed by United States India. Moreover, Chinese research institutions, notably Academy Sciences Shanghai Jiao Tong University, prevail output. Upon exclusion irrelevant search terms, keywords clustering highlights that “biomarkers”, “sensors”, “gold nanoparticles”, “silver nanoparticles” are predominant focuses. Conclusion furnishes quantitative perspective on extant literature, serving scholars related fields. Furthermore, anticipates future trend concerning diagnosis, aiding formulation project planning design experiments.

Language: Английский

Nanoparticle trends and hotspots in lung cancer diagnosis from 2006-2023: a bibliometric analysis DOI Creative Commons
Yilun Wang,

Zhang Yaojing,

Hongcan Shi

et al.

Frontiers in Oncology, Journal Year: 2024, Volume and Issue: 14

Published: Dec. 20, 2024

Background Lung cancer possesses the highest incidence and mortality rates among malignancies globally. Despite substantial advancements in oncology, it is frequently diagnosed at an advanced stage, resulting a poor prognosis. Over recent decades, swift progress of nanotechnology has precipitated extensive utilization nanomaterials as carriers diagnosis therapy. The deployment nanoparticles innovative diagnostic strategy aspires to enable earlier detection lung cancer, thereby permitting intervention enhancing This study endeavors deepen our understanding this domain through comprehensive analysis employing bibliometric tools. Method Related articles were retrieved from Web Science Core Collection January 1st, 2006, December 14st, 2023. Thereaf CiteSpace, VOSviewer online platform bibliometrics ( http://bibliometric.com/ ) utilized visually analyze Author/Country/Institutions/Cited Journals/Keyword, et al. Results A total 966 for study. unveils progressive increase annual publications within field, with China forefront publication volume, followed by United States India. Moreover, Chinese research institutions, notably Academy Sciences Shanghai Jiao Tong University, prevail output. Upon exclusion irrelevant search terms, keywords clustering highlights that “biomarkers”, “sensors”, “gold nanoparticles”, “silver nanoparticles” are predominant focuses. Conclusion furnishes quantitative perspective on extant literature, serving scholars related fields. Furthermore, anticipates future trend concerning diagnosis, aiding formulation project planning design experiments.

Language: Английский

Citations

1